Funding Update
UFHCC + Extramural Opportunities
UFHCC Opportunities
This is a selected list of internal cancer-focused funding opportunities. To stay updated, visit our webpage.
UFHCC Bridge Grants
This Bridge Grant Program is designed to support promising new research or competitive renewals that have nearly missed funding pay lines. The research must have strong cancer relevance; clinical, basic and population research grants are all acceptable. The maximum award for these grants is $75,000 direct cost for R01s and $50,000 for R21s. No IDC is allowed.
Applications will be accepted on a rolling basis. Applicants should submit their full federal proposal with a screenshot of their score/percentile to ResearchAdmin@cancer.ufl.edu.
For more information, see the UFHCC Bridge Grants page.
Other UF Opportunities
Clinical and Translational Science Institute
Patient Oriented Clinical Research
Application due date: Rolling basis through March 31, 2018
Extramural Opportunities
Limited Extramural Funding Opportunities
V Foundation for Cancer Research – 2018 Translational Research Award
Nomination due date: 4/16/18
Application due date: 5/30/18
Other Extramural Opportunities (Selected)
American Cancer Society
American Society of Hematology
| ASH Bridge Grant Application due date: 5/1/18 Brain Tumor Funders’ Collaborative Request for Pre-proposals: Immunotherapy for Primary Human Brain Tumors Chordoma Foundation Therapeutic Innovation Award Damon Runyon Cancer Research Foundation Damon Runyon-Rachleff Innovation Award Department of Defense – Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Cancer Funding Lung Cancer Funding Dresner Foundation Myelodysplastic Syndromes (MDS) Research Florida Breast Cancer Foundation Education Grant Applications Hope Foundation SWOG Early Exploration and Development (SEED) Fund National Institutes of Health Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21) Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations – An ORWH FY18 Administrative Supplement (Admin Supp Clinical Trial Optional) Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) National Cancer Institute Youth Enjoy Science Research Education Program (R25) Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R01 Clinical Trial Optional) Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trials Optional) Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention(R01 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed) Inter-organelle Communication in Cancer (R01) Inter-organelle Communication in Cancer (R21) Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Oncology Nursing Society Research Career Development Award Ovarian Cancer Research Fund Rosalind Franklin Prize for Excellence in Ovarian Cancer Research Pfizer ASPIRE Breast Cancer Research Awards Program The Cholangiocarcinoma Foundation Research Fellowships in Cholangiocarcinoma Translational Communication Research Pilot Project Awards |
